Lead sponsor
Lighthouse Pharmaceuticals, Inc.
1 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
1
Trials led
1
Ongoing
300
Total enrollment
38
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
1
Trials by status
Recruiting
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's DiseaseAge 55-80Ph 2Recruiting300